The team at NAVi has strengths in pediatric medicine, biomedical engineering and small business management. Together we share a vision to develop products that assist doctors, and ultimately deliver better standards of clinical care.
Central Lines (such as PICCs & UVCs) are frequently placed in critically ill newborns to deliver lifesaving drugs & nutrients. However, these procedures can be difficult since there is no real-time feedback during the procedure.
Navi is currently developing a clinical prototype for the neonav and will commence clinical trials in 2019.